110 related articles for article (PubMed ID: 3933404)
1. Mechanism of factor VIII inactivation by human antibodies. III. Proteolytic cleavage of factor VIII:C and C antigen by thrombin.
Lazarchick J; Ashby MA; Lazarchick JJ; Sens DA
Ann Clin Lab Sci; 1985; 15(6):482-7. PubMed ID: 3933404
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of factor VIII inactivation by human antibodies. IV. Antibody binding prevents factor VIII proteolysis by thrombin.
Lazarchick J; Ashby MA; Lazarchick JJ; Sens DA
Ann Clin Lab Sci; 1986; 16(6):497-501. PubMed ID: 3099625
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity.
Takeyama M; Nogami K; Matsumoto T; Soeda T; Suzuki T; Hattori K; Shima M
Thromb Haemost; 2010 Jan; 103(1):94-102. PubMed ID: 20062922
[TBL] [Abstract][Full Text] [Related]
4. The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation.
Hoyer LW; Trabold NC
J Lab Clin Med; 1981 Jan; 97(1):50-64. PubMed ID: 6778941
[TBL] [Abstract][Full Text] [Related]
5. Proteolysis of blood coagulation factor VIII by the factor VIIa-tissue factor complex: generation of an inactive factor VIII cofactor.
Warren DL; Morrissey JH; Neuenschwander PF
Biochemistry; 1999 May; 38(20):6529-36. PubMed ID: 10350471
[TBL] [Abstract][Full Text] [Related]
6. Characterization of four monoclonal antibodies to factor VIII coagulant protein and their use in immunopurification of factor VIII.
Croissant MP; van de Pol H; Lee HH; Allain JP
Thromb Haemost; 1986 Dec; 56(3):271-6. PubMed ID: 2436329
[TBL] [Abstract][Full Text] [Related]
7. Studies on a monoclonal antibody to human factor viii coagulant activity, with a description of a facile two-site factor VIII coagulant antigen assay.
Brown JE; Thuy LP; Carton CL; Hougie C
J Lab Clin Med; 1983 May; 101(5):793-805. PubMed ID: 6403639
[TBL] [Abstract][Full Text] [Related]
8. Factor VIII S373L: mutation at P1' site confers thrombin cleavage resistance, causing mild haemophilia A.
Johnson DJ; Pemberton S; Acquila M; Mori PG; Tuddenham EG; O'Brien DP
Thromb Haemost; 1994 Apr; 71(4):428-33. PubMed ID: 8052958
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to human procoagulant factor VIII.
Rotblat F; Goodall AH; O'Brien DP; Rawlings E; Middleton S; Tuddenham EG
J Lab Clin Med; 1983 May; 101(5):736-46. PubMed ID: 6403638
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII).
Pittman DD; Kaufman RJ
Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2429-33. PubMed ID: 3128786
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a form of bovine factor VIII which does not aggregate human platelets.
Kirby EP
Thromb Haemost; 1981 Aug; 46(2):479-84. PubMed ID: 6795738
[TBL] [Abstract][Full Text] [Related]
12. A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage.
Pittman DD; Millenson M; Marquette K; Bauer K; Kaufman RJ
Blood; 1992 Jan; 79(2):389-97. PubMed ID: 1730084
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
De Cristofaro R; De Filippis V
Biochem J; 2003 Jul; 373(Pt 2):593-601. PubMed ID: 12689334
[TBL] [Abstract][Full Text] [Related]
14. Structure and function of factor VIII procoagulant protein.
Fulcher CA; Zimmerman TS
Prog Clin Biol Res; 1984; 150():57-71. PubMed ID: 6431442
[No Abstract] [Full Text] [Related]
15. Thrombin proteolysis of purified factor viii procoagulant protein: correlation of activation with generation of a specific polypeptide.
Fulcher CA; Roberts JR; Zimmerman TS
Blood; 1983 Apr; 61(4):807-11. PubMed ID: 6403080
[TBL] [Abstract][Full Text] [Related]
16. Role of the B domain in proteolytic inactivation of activated coagulation factor VIII by activated protein C and activated factor X.
Khrenov AV; Ananyeva NM; Saenko EL
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):379-88. PubMed ID: 16788314
[TBL] [Abstract][Full Text] [Related]
17. Binding to phospholipid protects factor VIII from inactivation by human antibodies.
Barrowcliffe TW; Kemball-Cook G; Gray E
J Lab Clin Med; 1983 Jan; 101(1):34-43. PubMed ID: 6401316
[TBL] [Abstract][Full Text] [Related]
18. Thrombin potentiation of factor VIII procoagulant activity: assessment by the two-stage assay.
Kopitsky RG; Switzer ME; McKee PA
Thromb Haemost; 1982 Apr; 47(2):145-9. PubMed ID: 6213066
[TBL] [Abstract][Full Text] [Related]
19. Rabbit antibodies against the procoagulant activity (VIII:C) of human factor VIII. Some theoretical and practical considerations on the human factor VIII molecule using heterologous antibodies.
Tran TH; Marbet GA; Duckert F
Thromb Haemost; 1981 Dec; 46(4):699-705. PubMed ID: 6800051
[TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain.
Hill-Eubanks DC; Lollar P
J Biol Chem; 1990 Oct; 265(29):17854-8. PubMed ID: 2120219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
